Jamie Christensen - Jan 17, 2023 Form 4 Insider Report for Mirati Therapeutics, Inc. (MRTX)

Role
EVP, Chief Scientific Officer
Signature
/s/ Reena Desai, Attorney-in-Fact
Stock symbol
MRTX
Transactions as of
Jan 17, 2023
Transactions value $
-$95,142
Form type
4
Date filed
1/19/2023, 08:45 AM
Previous filing
Jan 5, 2023
Next filing
Jan 24, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRTX Common Stock Sale -$57.5K -1.36K -1.36% $42.38 98.8K Jan 17, 2023 Direct F1
transaction MRTX Common Stock Sale -$37.6K -887 -0.9% $42.38 97.9K Jan 17, 2023 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares sold by the Company to satisfy the tax withholding obligation associated with the vesting of a portion of the restricted stock units (RSUs) granted on January 14, 2022.
F2 Represents shares sold by the Company to satisfy the tax withholding obligation associated with the vesting of a portion of the restricted stock units (RSUs) granted on January 15, 2021.